Scientific information
Storage conditions
Pricing and ordering are available to registered accounts.
Sign in or create a free accountBioLean3 Reta is a precision-manufactured triple-agonist research compound associated with GLP-1, GIP, and Glucagon receptor pathway models. Supplied in a 30mg laboratory-grade vial, it is designed for analytical and investigational applications requiring compound stability and consistency.
For research use only. Not for human consumption.
In stock
Fulfillment timing is calculated from the current cutoff shown at the top of the site.
Review the published product information, specifications, and customer feedback for this catalog item.
BioLean3 Reta is a laboratory-grade research compound supplied in a 30mg precision vial, developed for scientific, analytical, and investigational applications involving multi-pathway metabolic receptor models.
Classified within the triple-agonist compound category, BioLean3 Reta is associated with receptor pathway interactions commonly studied in laboratory environments, including:
• GLP-1 signaling mechanisms
• GIP receptor activity
• Glucagon-related pathways
This multi-receptor profile makes BioLean3 Reta of particular interest in research settings examining complex regulatory and metabolic systems.
Manufactured using controlled synthesis and quality-focused handling standards, BioLean3 Reta is designed for professional laboratory use where compound integrity, stability, and batch consistency are critical.
✔ Product: BioLean3 Reta
✔ Fill Quantity: 30mg per vial
✔ Format: Laboratory-grade vial
✔ Classification: Triple-agonist research compound
✔ Packaging: Stability-preserving containment
Compounds within this classification are frequently explored in laboratory models involving:
• Multi-receptor metabolic pathways
• Appetite and regulatory signaling mechanisms
• Energy balance systems
• Glucose-associated biological processes
• Peptide-receptor interaction studies
The 30mg vial format supports extended research protocols, longitudinal analysis, and multi-phase experimental workflows.
✔ High-purity research compound
✔ Precision-filled 30mg vial
✔ Triple-agonist receptor classification
✔ Batch-controlled manufacturing
✔ Intended for laboratory professionals
BioLean3 Reta is:
• Produced using advanced synthesis processes
• Subjected to internal quality verification
• Evaluated for compound integrity
• Packaged to preserve stability and reliability
BioPure prioritizes precision, consistency, and professional-grade research standards across all compounds.
BioLean3 Reta is sold strictly for laboratory research and analytical purposes only.
NOT FOR HUMAN CONSUMPTION
NOT FOR MEDICAL, DIAGNOSTIC, OR THERAPEUTIC USE
Store following standard laboratory compound storage protocols. Protect from excessive heat, moisture, and light exposure. Refrigeration recommended where appropriate.
This product is supplied exclusively as a research material. By purchasing, the buyer acknowledges that BioLean3 Reta is not intended for human use and must be handled only by qualified professionals.
Documents appear here only when the compound, formulation, and labeled strength have been matched to this product.
Products from the same research area use the same live catalog card and pricing rules.
Articles from our research library that relate to this product.
BioLean3 Reta GGG is a triple-agonist research compound and BioLean2 Tirz GIP is a dual-agonist one. Here is how they differ on receptors, research areas and the COA.
Read article →A plain-language look at MOTS-C: its origin in mitochondrial DNA, what laboratory research has examined, how it is tested and how it is stored.
Read article →Plain answers on what BPC-157 is, what published laboratory research has examined, how it differs from TB500, and how the 10mg vial is tested and stored.
Read article →
